[Predictors of smoking cessation in group-based behavioral intervention programme--research findings in 2001-2007].Przegl Lek. 2008; 65(10):634-40.PL
The efficacy and cost-effectiveness of behavioral treatments compare favorably with the pharmacotherapies and community-based interventions. Group-based behavioral programmes have been scientifically proven as the effective smoking cessation intervention. Identifying predictors of the efficacy of smoking cessation within group-based programme using characteristics of participants (social and environmental approach). Program is a multicomponent group-based behavioral intervention with the elements recommended by the US Public Health Service as the most effective. 517 smokers were included into the program in the outpatient clinic setting in years 2001-2007. A point prevalence abstinence (PPA) was estimated by self-reported smoking cessation. 59.% of participants stopped smoking during four-week program. Using multivariate logistic regression, a model provided the optimal predictive ability. PPA decreased (odds ratio [OR], 0.7; 95% confidence interval [CI], 0.24-0.93) for manual occupied and unemployed participant comparing to nonmanual occupied smoker, decreased (OR, 0.9; 95% CI, 0.20-1.19) for high-nicotine-dependent smoker, increased (OR, 1.49; 95% CI, 0.74-2.98) for high-motivated to quit smoking participant, increased (OR 2.31; 95% CI, 1.15-4.66) for subject smoked 1 pack or more of cigarettes per day, decreased (OR 1.41; 95% CI, 0.85-2.35) for participant with smoker in household, decreased (OR 1.74; 95% CI, 1.09-2.78) for smoker without any previous physician's advice to quit and did not distinguish for subject without any previous attempts. The future of behavioral group-based treatment will likely emphasize intensive intervention targeted to particular subgroups of smokers with the need and motivation for them (eg, the low nicotine-dependent but with high emotional and/or behavioral components of dependency, poor supported by family and non-medical patients). A blurring of the distinctions between behavioral interventions, pharmacotherapies, and community-oriented approaches is also likely as multidimensional cessation strategies are developed.